Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
20 02 2020
20 02 2020
Historique:
received:
27
07
2019
accepted:
30
01
2020
entrez:
22
2
2020
pubmed:
23
2
2020
medline:
13
11
2020
Statut:
epublish
Résumé
A rigidification strategy was applied to the preclinical candidate donecopride, an acetylcholinesterase inhibitor possessing 5-HT
Identifiants
pubmed: 32080261
doi: 10.1038/s41598-020-59805-7
pii: 10.1038/s41598-020-59805-7
pmc: PMC7033111
doi:
Substances chimiques
Cholinesterase Inhibitors
0
Isoxazoles
0
Receptors, Serotonin, 5-HT4
158165-40-3
Donepezil
8SSC91326P
Acetylcholinesterase
EC 3.1.1.7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3014Références
World Alzheimer Report. The state of the art of dementia research: New frontiers, https://www.alz.co.uk/research/world-report-2018 (2018)
Stelzmann, R. A., Schnitzlein, H. N. & Murtagh, F. R. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin. Anat. 8, 429–431, https://doi.org/10.1002/ca.980080612 (1995).
doi: 10.1002/ca.980080612
pubmed: 8713166
Bird, T. D. Genetic aspects of Alzheimer disease. Genet. Med. 10, 231–239, https://doi.org/10.1097/GIM.0b013e31816b64dc (2008).
doi: 10.1097/GIM.0b013e31816b64dc
pubmed: 18414205
pmcid: 2690397
Melnikova, I. Therapies for Alzheimer’s disease. Nat. Rev. Drug. Discov. 6, 341–342, https://doi.org/10.1038/nrd2314 (2007).
doi: 10.1038/nrd2314
pubmed: 17539055
Cummings, J. L., Morstorf, T. & Zhong, K. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimer’s Res. Ther. 6, 37, https://doi.org/10.1186/alzrt269 (2014).
doi: 10.1186/alzrt269
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P. & Kivipelto, M. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol. 9, 702–716, https://doi.org/10.1016/S1474-4422(10)70119-8 (2010).
doi: 10.1016/S1474-4422(10)70119-8
pubmed: 20610346
Morphy, R. & Rankovic, Z. Designed multiple ligands. An emerging drug discovery paradigm. J. Med. Chem. 48, 6523–6543, https://doi.org/10.1021/jm058225d (2005).
doi: 10.1021/jm058225d
pubmed: 16220969
Cavalli, A. et al. Multi-target-directed ligands to combat neurodegenerative diseases. J. Med. Chem. 51, 347–372, https://doi.org/10.1021/jm7009364 (2008).
doi: 10.1021/jm7009364
pubmed: 18181565
Lewis, W. G. et al. Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. Angew Chem Int Ed 41, 1053–1057, 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4 (2002).
doi: 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4
Garcia-Palomero, E. et al. Potent beta-amyloid modulators. Neurodegener. Dis. 5, 153–156, https://doi.org/10.1159/000113688 (2008).
doi: 10.1159/000113688
pubmed: 18322376
Inestrosa, N. C., Sagal, J. P. & Colombres, M. Acetylcholinesterase interaction with Alzheimer amyloid beta. Subcell. Biochem. 38, 299–317, https://doi.org/10.1007/0-387-23226-5_15 (2005).
doi: 10.1007/0-387-23226-5_15
pubmed: 15709485
Alvarez, A. et al. Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer’s fibrils. J. Neurosci. 18, 3213–3223, https://doi.org/10.1523/JNEUROSCI.18-09-03213.1998 (1998).
doi: 10.1523/JNEUROSCI.18-09-03213.1998
pubmed: 9547230
pmcid: 6792661
Reyes, A. E. et al. Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am. J. Pathol. 164, 2163–2174, https://doi.org/10.1016/S0002-9440(10)63774-1 (2004).
doi: 10.1016/S0002-9440(10)63774-1
pubmed: 15161650
pmcid: 1615768
Agis-Torres, A., Sollhuber, M., Fernandez, M. & Sanchez-Montero, J. M. Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease. Curr. Neuropharmacol. 12, 2–36, https://doi.org/10.2174/1570159X113116660047 (2014).
doi: 10.2174/1570159X113116660047
pubmed: 24533013
pmcid: 3915347
Kowal, N. M. et al. Novel Approach for the Search for Chemical Scaffolds with Activity at Both Acetylcholinesterase and the α7 Nicotinic Acetylcholine Receptor: A Perspective on Scaffolds with Dual Activity for the Treatment of Neurodegenerative Disorders. Molecules 24, 446, https://doi.org/10.3390/molecules24030446 (2019).
doi: 10.3390/molecules24030446
pmcid: 6384821
Lalut, J., Rochais, C. & Dallemagne, P. Multiple Ligands in Neurodegenerative Diseases, Drug Selectivity – An Evolving Concept in Drug Discovery, Book series “Methods and Principles in Medicinal Chemistry”, Wiley-VCH Publishing House. https://doi.org/10.1002/9783527674381.ch16 (2017).
Lecoutey, C. et al. Synthesis of dual AChE/5-HT4 receptor multi-target directed ligands. Med. Chem. Commun. 3, 627–634, https://doi.org/10.1039/c2md20063e (2012).
doi: 10.1039/c2md20063e
Jourdan, J.-P. et al. Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer’s disease treatment. Eur. J. Med. Chem. 114, 365–379, https://doi.org/10.1016/j.ejmech.2016.03.023 (2016).
doi: 10.1016/j.ejmech.2016.03.023
pubmed: 27046230
Lalut, J. et al. Novel Multitarget-Directed Ligands Targeting Acetylcholinesterase and σ1 Receptors as Lead Compounds for Treatment of Alzheimer’s Disease: Synthesis, Evaluation, and Structural Characterization of their Complexes with Acetylcholinesterase. Eur. J. Med. Chem. 162, 234–248, https://doi.org/10.1016/j.ejmech.2018.10.064 (2019).
doi: 10.1016/j.ejmech.2018.10.064
pubmed: 30447434
Lecoutey, C. et al. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer’s disease treatment. Proc. Natl Acad. Sci. US 111, E3825–E3830, https://doi.org/10.1073/pnas.1410315111 (2014).
doi: 10.1073/pnas.1410315111
Bockaert, J., Claeysen, S., Compan, V. & Dumuis, A. 5-HT(4) receptors: history, molecular pharmacology and brain functions. Neuropharmacol. 55, 922–931, https://doi.org/10.1016/j.neuropharm.2008.05.013 (2008).
doi: 10.1016/j.neuropharm.2008.05.013
Matsumoto, M. et al. Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: Behavioral, electrophysiological, and neurochemical studies. J. Pharmacol. Exp. Ther. 296, 676–682 (2001).
pubmed: 11181892
Consolo, S., Arnaboldi, S., Giorgi, S., Russi, G. & Ladinsky, H. 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport 5, 1230–1232, https://doi.org/10.1097/00001756-199406020-00018 (1994).
doi: 10.1097/00001756-199406020-00018
pubmed: 7919171
Lamirault, L. & Simon, H. Enhancement of place and object recognition memory in young adult and old rats by RS67333, a partial agonist of 5-HT4 receptors. Neuropharmacol. 41, 844–853, https://doi.org/10.1016/S0028-3908(01)00123-X (2001).
doi: 10.1016/S0028-3908(01)00123-X
Russo, O. et al. Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer’s disease. J. Med. Chem. 52, 2214–2225, https://doi.org/10.1021/jm801327q (2009).
doi: 10.1021/jm801327q
pubmed: 19334715
Freret, T. Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT4 receptor activation (RS67333) on object recognition in mice. A new hope to design a treatment for Alzheimer’s disease. Behav. Brain Res. 230, 304–308, https://doi.org/10.1016/j.bbr.2012.02.012 (2012).
doi: 10.1016/j.bbr.2012.02.012
pubmed: 22348892
Villalobos, A. et al. Novel Benzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase. J. Med. Chem. 37, 2721–2734, https://doi.org/10.1021/jm00043a012 (1994).
doi: 10.1021/jm00043a012
pubmed: 8064800
Sugimoto, H. et al. Novel Piperidine Derivatives. Synthesis and Anti-Acetylcholinesterase Activity of 1-Benzyl-4-[2-(N-benzoylamino)ethyl]piperidine Derivatives. J. Med. Chem. 33, 1880–1887, https://doi.org/10.1021/jm00169a008 (1990).
doi: 10.1021/jm00169a008
pubmed: 2362265
Brodney, M. A. et al. Identification of Multiple 5-HT
doi: 10.1021/jm300953p
pubmed: 22974325
Dubrovskiy, A. V. & Larock, R. C. Synthesis of Benzisoxazoles by the [3 + 2] Cycloaddition of in situ Generated Nitrile Oxides and Arynes. Org. Lett. 12, 1180–1183, https://doi.org/10.1021/ol902921s (2010).
doi: 10.1021/ol902921s
pubmed: 20184347
pmcid: 2852127
Chen, C.-y et al. A Divergent and Selective Synthesis of Isomeric Benzoxazoles from a Single N–Cl Imine. Org. Lett. 13, 6300–6303, https://doi.org/10.1021/ol202844c (2011).
doi: 10.1021/ol202844c
pubmed: 22067007
Shutske, G. M. A new synthesis of 3-phenyl-1,2-benzisoxazoles: sterically constrained 3-phenyl-1,2-benzisoxazoles by intramolecular carbon:nitrogen bond formation at a hindered carbonyl group. J. Org. Chem. 49, 180–183, https://doi.org/10.1021/jo00175a042 (1984).
doi: 10.1021/jo00175a042
Liu, W. et al. Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators. J. Med. Chem. 54, 8541–8554, https://doi.org/10.1021/jm201061j (2011).
doi: 10.1021/jm201061j
pubmed: 22070604
Hoare, D. G. et al. The reaction of hydroxamic acids with water-soluble carbodiimides. A lossen rearrangement. J. Am. Chem. Soc. 90, 1638–1643, https://doi.org/10.1021/ja01008a040 (1968).
doi: 10.1021/ja01008a040
pubmed: 5636802
Mitsunobu, O. & Yamada, M. Preparation of Esters of Carboxylic and Phosphoric Acid via Quaternary Phosphonium Salts. Bull. Chem. Soc. Jpn. 40, 2380–2382, https://doi.org/10.1246/bcsj.40.2380 (1967).
doi: 10.1246/bcsj.40.2380
Udd, S. et al. Copper-catalyzed cyclization of Z-oximes into 3-methyl-1,2-benzisoxazoles. Tetrahedron Lett. 51, 1030–1033, https://doi.org/10.1016/j.tetlet.2009.12.070 (2010).
doi: 10.1016/j.tetlet.2009.12.070
Iranpoor, N. et al. A novel method for the highly efficient synthesis of 1,2-benzisoxazoles under neutral conditions using the Ph3P/DDQ system. Tetrahedron Lett. 47, 8247–8250, https://doi.org/10.1016/j.tetlet.2006.09.120 (2006).
doi: 10.1016/j.tetlet.2006.09.120
Alvaro, G. et al. Dérivés d’hydantoïne utiles en tant qu’inhibiteurs de kv3. WO 2012/076877 A1 (2012).
Ellman, G. L. et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88–95, https://doi.org/10.1016/0006-2952(61)90145-9 (1961).
doi: 10.1016/0006-2952(61)90145-9
pubmed: 13726518
Grossman, C. J. et al. Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br. J. Pharmacol. 109, 618–624, https://doi.org/10.1111/j.1476-5381.1993.tb13617.x (1993).
doi: 10.1111/j.1476-5381.1993.tb13617.x
pubmed: 8358562
pmcid: 2175660
Rochais, C. et al. Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT
doi: 10.1021/acs.jmedchem.5b00115
pubmed: 25793650
Cheung, J. et al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J. Med. Chem. 55, 10282–10286, https://doi.org/10.1021/jm300871x (2012).
doi: 10.1021/jm300871x
pubmed: 23035744
Jones, G., Willett, P. & Glen, R. C. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245, 43–53, https://doi.org/10.1016/S0022-2836(95)80037-9 (1995).
doi: 10.1016/S0022-2836(95)80037-9
pubmed: 7823319
Jones, G. et al. Development and Validation of a Genetic Algorithm for Flexible Docking. J. Mol. Biol. 267, 727–748, https://doi.org/10.1006/jmbi.1996.0897 (1997).
doi: 10.1006/jmbi.1996.0897
pubmed: 9126849
Discovery Studio Modeling Environment, release 4.5, San Diego, CA: (2012).
Dubost, E. et al. Synthesis and Structure-Affinity Relationships of Selective High-Affinity 5-HT4 Receptor Antagonists: Application to the Design of New Potential Single Photon Emission Computed Tomography Tracers. J. Med. Chem. 55, 9693–9707, https://doi.org/10.1021/jm300943r (2012).
doi: 10.1021/jm300943r
pubmed: 23102207
pmcid: 3509320
Cherezov, V. et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Sci. 318, 1258–1265, https://doi.org/10.1126/science.1150577 (2007).
doi: 10.1126/science.1150577
Rivail, L. et al. New insights into the human 5-HT4 receptor binding site:Exploration of a hydrophobic pocket. Br. J. Pharmacol. 143, 361–370, https://doi.org/10.1038/sj.bjp.0705950 (2004).
doi: 10.1038/sj.bjp.0705950
pubmed: 15351779
pmcid: 1575351